GSK2194069 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor of fatty acid synthase (FASN), an enzyme that plays a critical role in the synthesis of fatty acids. By inhibiting FASN, GSK2194069 disrupts the lipid metabolism in cancer cells, which is essential for their growth and survival. This makes it a valuable tool in preclinical studies aimed at understanding the metabolic pathways of cancer cells and developing targeted treatments. Researchers also explore its potential in combination therapies to enhance the efficacy of existing anticancer drugs. Its application extends to the investigation of metabolic disorders and the exploration of novel therapeutic strategies in oncology.